Sandra W Curtiss

Title: Innovations by Sandra W Curtiss in Carcinogenesis Research.

Introduction

Sandra W Curtiss is a notable inventor based in Ellisville, MO (US). She has made significant contributions to the field of carcinogenesis through her innovative research and patents. Her work focuses on biomarkers and assays that are crucial for understanding cancer development.

Latest Patents

Sandra holds a patent titled "Biomarkers and assays for carcinogenesis." This invention relates to carcinogenesis biomarkers produced by phenobarbital-treated rat hepatocytes. It includes nucleic acid molecules that encode these biomarkers or fragments thereof, as well as nucleic acid molecules that serve as probes or primers for detecting or inducing carcinogenesis. The invention also encompasses applications of these factors or fragments, such as forming antibodies capable of binding to the carcinogenesis biomarkers or their fragments.

Career Highlights

Sandra W Curtiss has worked at G.D. Searle & Company, where she has been able to apply her expertise in the field of carcinogenesis. Her innovative approach has led to advancements in understanding cancer mechanisms and potential diagnostic tools.

Collaborations

Throughout her career, Sandra has collaborated with notable colleagues, including Roderick T Bunch and Dale Lynn Morris. These collaborations have further enriched her research and contributed to the development of her patented innovations.

Conclusion

Sandra W Curtiss is a pioneering inventor whose work in carcinogenesis has led to valuable insights and advancements in cancer research. Her contributions continue to impact the scientific community and enhance our understanding of cancer biomarkers.